David Stabile

• Ranked among the top 25% nationally in both 2023 and 2024, exceeding quota during that time.

• Drove 38.12% year-over-year growth in patient population (December 2023 - December 2024) through territory analysis and innovative sales

initiatives

• Proven success in driving sales for new indications and product launches, establishing 3,000 monthly prescription fills for the Freestyle Libre 3 within

its first year of launch.

• Proven leader and team contributor serving as District Sales Trainer, Field Insight Rep, and Leadership Advisory Council Member to support training, strategy, and cross-functional initiatives.

• Developed and led a data-driven Impact Project implemented across the district, resulting in a 50.89% increase in new patient starts within key accounts during the 2024-2025 calendar year.

• Successfully recruited and onboarded Dr. David Ahn, a key opinion leader within the community, as an Abbott Speaker.

• Proactively pursued professional growth with Abbott's support to attend the course, 'High Impact Presentation Skills'.

• Recognized as 2024 Regional MVP and Q3 2024 ‘Frontier of the Quarter’ for exceptional sales performance and organizational leadership.

• Consistently exceeded sales targets, growing the monthly prescription total by approximately 300% in my first year by expanding market share and strengthening key customer relationships.

• Recorded company record for most device referrals within a quarter.

• Ranked #1/37 in national leaderboard when leaving for new opportunity at Abbott.

• Responsible for calling on Endocrinologists, Internal Medicine, and Family Practice doctors in selling and training patients on continuous glucose monitors.

• Undertook the role of Field Sales Trainer, assisted in mentoring new reps in the division.

• Enhanced team collaboration through regular communication channels, fostering a positive work environment where ideas could flourish.

• Pioneered a new testing location and aided in the startup of a CLIA certified medical facility that served thousands of patients.

• Developed sales initiatives based upon constantly changing regulations, greatly increasing testing numbers as COVID-19 cases slowed down.

• Instituted contractual partnerships with adjacent laboratories, optimizing our overnight PCR testing procedures, expanding our PCR testing capacity,

and stimulating substantial business growth.